Expert Review of Anticancer Therapy

2.7(top 20%)

impact factor

2.6K(top 10%)

papers

53.3K(top 5%)

citations

81(top 10%)

h-index

2.9(top 20%)

impact factor

3.4K

all documents

56.5K

doc citations

116(top 10%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Current and future therapeutic approaches for osteosarcoma	Expert Review of Anticancer Therapy	2018	539
2	HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies	Expert Review of Anticancer Therapy	2011	368
3	Chemotherapy resistance in osteosarcoma: current challenges and future directions	Expert Review of Anticancer Therapy	2006	334
4	Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor	Expert Review of Anticancer Therapy	2007	303
5	Overview and recent advances in the treatment of neuroblastoma	Expert Review of Anticancer Therapy	2017	286
6	The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care	Expert Review of Anticancer Therapy	2018	268
7	A new understanding in the epidemiology of melanoma	Expert Review of Anticancer Therapy	2010	264
8	Nonhistone protein acetylation as cancer therapy targets	Expert Review of Anticancer Therapy	2010	257
9	Inflammation in the development of lung cancer: epidemiological evidence	Expert Review of Anticancer Therapy	2008	237
10	Metastatic osteosarcoma: a challenging multidisciplinary treatment	Expert Review of Anticancer Therapy	2016	218
11	Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors	Expert Review of Anticancer Therapy	2010	215
12	Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy	Expert Review of Anticancer Therapy	2009	206
13	Head and neck cancer: past, present and future	Expert Review of Anticancer Therapy	2006	199
14	Management of soft tissue sarcomas of the extremities	Expert Review of Anticancer Therapy	2004	198
15	Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases	Expert Review of Anticancer Therapy	2010	177
16	Nanotechnology for targeted cancer therapy	Expert Review of Anticancer Therapy	2007	175
17	Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer	Expert Review of Anticancer Therapy	2018	172
18	The role of platelet activation in tumor metastasis	Expert Review of Anticancer Therapy	2008	165
19	A comprehensive review of protein kinase inhibitors for cancer therapy	Expert Review of Anticancer Therapy	2018	164
20	Oncolytic viruses: a novel form of immunotherapy	Expert Review of Anticancer Therapy	2008	154
21	Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles	Expert Review of Anticancer Therapy	2016	153
22	Current systemic therapy for metastatic melanoma	Expert Review of Anticancer Therapy	2009	151
23	Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade	Expert Review of Anticancer Therapy	2012	144
24	Development of histone deacetylase inhibitors for cancer treatment	Expert Review of Anticancer Therapy	2007	141
25	The role of Gliadel wafers in the treatment of high-grade gliomas	Expert Review of Anticancer Therapy	2013	140
26	Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis	Expert Review of Anticancer Therapy	2004	138
27	Autophagy and endocrine resistance in breast cancer	Expert Review of Anticancer Therapy	2011	137
28	Stathmin 1: a novel therapeutic target for anticancer activity	Expert Review of Anticancer Therapy	2008	130
29	Recent advances in the prevention and treatment of skin cancer using photodynamic therapy	Expert Review of Anticancer Therapy	2010	129
30	MYC in breast tumor progression	Expert Review of Anticancer Therapy	2008	128
31	Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review	Expert Review of Anticancer Therapy	2017	128
32	Anti-GD2 immunotherapy for neuroblastoma	Expert Review of Anticancer Therapy	2017	128
33	MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century	Expert Review of Anticancer Therapy	2009	126
34	Screening of colorectal cancer: present and future	Expert Review of Anticancer Therapy	2017	123
35	Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma	Expert Review of Anticancer Therapy	2004	122
36	Present and potential future issues in glioblastoma treatment	Expert Review of Anticancer Therapy	2006	120
37	New treatment strategies for malignant gliomas	Expert Review of Anticancer Therapy	2006	117
38	Current epidemiological trends and surveillance issues in brain tumors	Expert Review of Anticancer Therapy	2001	116
39	Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial	Expert Review of Anticancer Therapy	2009	116
40	Bexarotene: a clinical review	Expert Review of Anticancer Therapy	2004	111
41	ROS1 as a ‘druggable’ receptor tyrosine kinase: lessons learned from inhibiting the ALK pathway	Expert Review of Anticancer Therapy	2012	111
42	The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review	Expert Review of Anticancer Therapy	2017	111
43	Lapatinib in the treatment of breast cancer	Expert Review of Anticancer Therapy	2007	110
44	Review of image-guided radiation therapy	Expert Review of Anticancer Therapy	2007	109
45	Molecular mechanisms of temozolomide resistance in glioblastoma multiforme	Expert Review of Anticancer Therapy	2012	109
46	Optimizing treatment in recurrent epithelial ovarian cancer	Expert Review of Anticancer Therapy	2017	107
47	Oral and Oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route	Expert Review of Anticancer Therapy	2019	107
48	The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy	Expert Review of Anticancer Therapy	2016	106
49	Mathematical modeling of cancer progression and response to chemotherapy	Expert Review of Anticancer Therapy	2006	105
50	Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma	Expert Review of Anticancer Therapy	2009	104

Scientometrics

Overviews

Citing Bodies

Expert Review of Anticancer Therapy

Top Articles